Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

286 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.
Montgomery SA, Kennedy SH, Burrows GD, Lejoyeux M, Hindmarch I. Montgomery SA, et al. Int Clin Psychopharmacol. 2004 Sep;19(5):271-80. doi: 10.1097/01.yic.0000137184.64610.c8. Int Clin Psychopharmacol. 2004. PMID: 15289700 Clinical Trial.
Features of recurrent brief depression.
Montgomery SA, Montgomery D. Montgomery SA, et al. Among authors: montgomery d. Encephale. 1992 Sep;18 Spec No 4:521-3. Encephale. 1992. PMID: 1308849
Fluvoxamine in the treatment of obsessive compulsive disorder.
Montgomery SA, Manceaux A. Montgomery SA, et al. Int Clin Psychopharmacol. 1992 Jun;7 Suppl 1:5-9. doi: 10.1097/00004850-199206001-00003. Int Clin Psychopharmacol. 1992. PMID: 1355499 Review.
The advantages of paroxetine in different subgroups of depression.
Montgomery SA. Montgomery SA. Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:91-100. doi: 10.1097/00004850-199206004-00015. Int Clin Psychopharmacol. 1992. PMID: 1431017
Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression.
Montgomery SA, Rasmussen JG, Lyby K, Connor P, Tanghøj P. Montgomery SA, et al. Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:65-70. doi: 10.1097/00004850-199206005-00007. Int Clin Psychopharmacol. 1992. PMID: 1431024 Clinical Trial. No abstract available.
Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression.
Montgomery SA, Rasmussen JG. Montgomery SA, et al. Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:71-3. doi: 10.1097/00004850-199206005-00008. Int Clin Psychopharmacol. 1992. PMID: 1431025 Clinical Trial. No abstract available.
The provocation and prevention of suicide attempts.
Montgomery SA, Bullock T, Baldwin D, Montgomery DB. Montgomery SA, et al. Among authors: montgomery db. Int Clin Psychopharmacol. 1992 Jun;6 Suppl 6:28-34. doi: 10.1097/00004850-199206006-00005. Int Clin Psychopharmacol. 1992. PMID: 1431028 Review. No abstract available.
The nature and recurrence of RBD on placebo.
Bullock T, Montgomery D, Baldwin D, Green M, Montgomery SA. Bullock T, et al. Among authors: montgomery d, montgomery sa. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:11A-12A. doi: 10.1097/00002826-199201001-00005. Clin Neuropharmacol. 1992. PMID: 1498772 No abstract available.
Has recurrent brief depression a different pharmacology.
Montgomery D, Green M, Bullock T, Baldwin D, Montgomery SA. Montgomery D, et al. Among authors: montgomery sa. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:13A-14A. doi: 10.1097/00002826-199201001-00006. Clin Neuropharmacol. 1992. PMID: 1498780 No abstract available.
Scientific advances and risk benefit issues in the treatment of depressive disorders.
Montgomery SA. Montgomery SA. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:336A-337A. doi: 10.1097/00002826-199201001-00174. Clin Neuropharmacol. 1992. PMID: 1498861 No abstract available.
286 results
Jump to page
Feedback